🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Xi’an
Clinical trial register · China

Clinical Trials in Xi’an, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Xijing Hospital124 Tang-Du Hospital49 First Affiliated Hospital Xi'an Jiaotong University41 Air Force Military Medical University, China19 Xijing Hospital of Digestive Diseases19
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Xi’an

504 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Study of Individualized, Precise and Standardized Cervical Open-door Surgery for Cervical Spinal Stenosis
NCT05786313Cervical Spinal Stenosis, Cervical Spinal Cord Injury, Individuation, Standardization
Xijing Hospital
Not applicable
500
Xi'an
2023-03-01
Recruiting
Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis
NCT05751967Primary Biliary Cholangitis
DrugsFenofibrate·Ursodeoxycholic Acid
Xijing Hospital of Digestive Diseases
Phase 3
150
Lanzhou, Guangzhou, Nanjing, Shenyang, Xi'an, Chengdu, Tianjin
2023-02-22
Recruiting
Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
NCT05749822Primary Biliary Cholangitis
Xijing Hospital of Digestive Diseases
Phase 2/3
104
Beijing, Guangzhou, Zhengzhou, Changsha, Nanjing, Shenyang, Xi'an, Yan’an
2023-02-17
Active, closed
SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors
NCT05642780Solid Tumor
DrugsSacituzumab tirumotecan·Pembrolizumab
Klus Pharma Inc.
Phase 2
240
Guangzhou, Nanning, Wuhan, Changsha, Changchun, Dalian, Weifang, Xi’an
2023-01-17
Not yet open
Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma
NCT05681403Lymphoma, Autologous Hematopoietic Stem Cell Transplantation
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
53
Xi'an
2023-01-15
Recruiting
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
NCT05614739Urinary Bladder Neoplasms, Neoplasm Metastasis, Ureteral Neoplasms
DrugsVepugratinib·Digoxin·Rosuvastatin·Enfortumab Vedotin
Eli Lilly and Company
Phase 1
677
Beijing, Guangdong, Hangzhou, Shanghai, Tianjin, Xi'an, Zhejiang
2023-01-12
Recruiting
Registry Study for Optimal Management of Liver Failure in the Chinese Population
NCT05740696Liver Failure
First Affiliated Hospital Xi'an Jiaotong University
Observational
500
Xi'an, Ankang, Changsha, Hanzhong, Jinan, Lanzhou, Weinan, Xianyang
2023-01-06
Recruiting
99mTc-P137 SPECT/CT in Prostate Cancer
NCT05672485Prostate Cancer
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
40
Xi'an
2023-01-05
By invitation
Comparison of Sublobar and Lobectomy in Small (2 Cm or Less 0.5<CTR<1) Non-small Cell Lung Cancer: a Prospective, Multicenter Randomized Controlled Study
NCT06028412NSCLC, Stage I
Xiaolong Yan, Dr.
Not applicable
660
Xi'an
2023-01-01
Recruiting
Researching the Useful of Barb Suture in Obese Patients Undergoing Posterior Cervical Surgery
NCT05895968Cervical Spinal Stenosis, Posterior Cervical Spine Surgery, Barbed Suture
Xijing Hospital
Not applicable
60
Xi'an
2023-01-01
Recruiting
Single Port Endoscopic Breast Conserving Surgery
NCT06593132Breast Conserving Surgery, Endoscopic Surgery
Ren,Yu
Observational
200
Xi'an
2023-01-01
Recruiting
Clinical Value of Saline Infusion Sonohysterography in the Assessment of Cesarean Scar Defects
NCT07610668Infertility
Tang-Du Hospital
Observational
300
Xi'an
2023-01-01
Recruiting
The Clinical Course and Factors for the Progression of Uninvestigated Dyspepsia to Functional Dyspepsia
NCT05823636Dyspepsia
Air Force Military Medical University, China
Observational
220
Xi'an
2023-01-01
Recruiting
Correlation Between Parameters and Prognosis of Cervical Single Open-door Surgery
NCT05767164Cervical Spinal Stenosis
Xijing Hospital
Not applicable
500
Xi'an
2023-01-01
Recruiting
Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics
NCT06001073Coronary Artery Disease, Arrhythmias, Cardiac, Heart Valve Diseases, Aortic Dissection
First Affiliated Hospital Xi'an Jiaotong University
Observational
25,000
Xi'an
2022-12-05
Active, closed
Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer
NCT05558722Breast Cancer Stage II
Xijing Hospital
Phase 2
31
Xi'an
2022-12-05
Active, closed
To Explore the Influencing Factors and Solutions for Patients With Plaque Psoriasis Undergoing Relapse
NCT07730619Plaque Psoriasis, Biologic Agents, Relapse, Influence Factors
First Affiliated Hospital Xi'an Jiaotong University
Observational
140
Xi'an
2022-12-01
Recruiting
Evaluation and Prediction of the Effect of EECP on HR-NICE Patients
NCT05718622Stroke, Ischemic
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
100
Xi'an
2022-11-10
By invitation
Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma
NCT05844813Retroperitoneal Sarcoma
Peking University International Hospital
Phase 4
102
Beijing, Qingdao, Shanghai, Xi’an
2022-11-01
Not yet open
Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma
NCT05539118Melanoma
Xijing Hospital
Phase 1/2
48
Xi'an
2022-09-30
Recruiting
LAAO Versus NOAC in Patients with AF and PCI
NCT05353140Atrial Fibrillation, Percutaneous Coronary Intervention
DrugsClopidogrel·Rivaroxaban·Aspirin
Xijing Hospital
Not applicable
1,386
Xi'an
2022-09-01
Active, closed
Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis
NCT07071246Treatment
DrugRituximab
Tang-Du Hospital
Not applicable
30
Xi'an
2022-08-01
Recruiting
Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell
NCT06006650Neoadjuvent, PD-1 Inhibitor, Chemotherapy, Esophageal Squamous Cell Carcinoma
Tang-Du Hospital
Phase 2
114
Xi'an, Xi’an
2022-08-01
Recruiting
Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis
NCT05067348Myasthenia Gravis, Generalized
Tang-Du Hospital
Phase 2
64
Beijing, Changsha, Xi'an, Shanghai, Chengdu, Tianjin
2022-07-21
Recruiting
Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)
NCT05443841Esophageal Cancer
Fudan University
Observational
385
Hefei, Shijiazhuang, Zhengzhou, Nantong, Taishing, Taizhou, Xi'an, Tianjin
2022-07-18
Active, closed
INSPIRIS China PMCF Study
NCT05404880Aortic Valve Replacement
Edwards Lifesciences
Observational
255
Hefei, Beijing, Xiamen, Guangzhou, Shenzhen, Zhengzhou, Nanjing, Xi’an
2022-07-13
Recruiting
The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer
NCT05984485Rectal Cancer
Sun Yat-sen University
Phase 3
766
Chongqing, Guangzhou, Hengyang, Shenyang, Xi'an, Nanchong
2022-07-05
Recruiting
Ofatumumab in AQP4-IgG Seropositive NMOSD
NCT05504694Neuromyelitis Optica Spectrum Disorder
DrugOfatumumab
Tang-Du Hospital
Phase 1/2
5
Xi'an
2022-06-28
Active, closed
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
NCT04975997Multiple Myeloma
DrugsIberdomide·Bortezomib·Daratumumab·Dexamethasone
Celgene
Phase 3
939
Changsha, Nanchang, Xi'an, Shanghai, Taiyuan, Wenzhou, Beijing, Changchun
2022-06-23
Recruiting
Application of Standardized Green Channel Treatment System for Ischemic Stroke in Xi 'an
NCT05424978Acute Ischemic Stroke, Thrombolysis, Endovascular Treatment
Xi'an No.3 Hospital
Observational
3,600
Xi'an
2022-06-01
Recruiting
Assessment of Brain Cognitive Impairment in Breast Cancer
NCT05305092Breast Cancer, Chemo-brain, Endocrine Therapy
Tang-Du Hospital
Observational
90
Xi'an
2022-05-31
Active, closed
The Influence of Splenic Artery Characteristics in Gastric Cancer Surgery
NCT06680362Gastrectomy, Gastric Carcinoma
xiaohua li
Observational
176
Xi'an
2022-05-22
Recruiting
The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV
NCT05690802Nausea and Vomiting
DrugPalonosetron hydrochloride
Xijing Hospital
Not applicable
1,060
Xi'an
2022-05-16
Recruiting
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
NCT05179876Hypertension, Pulmonary
DrugsSelexipag·Macitentan
Actelion
Phase 3
280
Beijing, Changsha, Nanjing, Qingdao, Shanghai, Xi'an
2022-05-04
Recruiting
Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric Junction
NCT05356520Siewert Type II Adenocarcinoma of Esophagogastric Junction
Xijing Hospital of Digestive Diseases
Not applicable
212
Xi'an
2022-05-01
By invitation
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab
NCT05303532Cancer
DrugDurvalumab
AstraZeneca
Phase 3
214
Beijing, Changsha, Hangzhou, Nanjing, Shanghai, Shenyang, Wenzhou, Xi'an
2022-04-19
Recruiting
Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)
NCT05145361NMO Spectrum Disorder
DrugB001
Shanghai Pharmaceuticals Holding Co., Ltd
Phase EARLY_PHASE1
45
Beijing, Taiyuan, Xi’an, Tianjin
2022-04-07
Active, closed
STOPS Trial: Total vs Subtotal Colectomy for Slow Transit Constipation
NCT05352074Slow Transit Constipation, Surgery
Third Military Medical University
Not applicable
252
Yuzhong, Lanzhou, Wuhan, Nanjing, Shengyang, Qingdao, Pudong, Xi’an
2022-03-27
Recruiting
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
NCT05201781Multiple Myeloma
DrugCilta-cel
Janssen Research & Development, LLC
Phase 4
295
Beijing, Chengdu, Fuzhou, Guangzhou, Hangzhou, Nanjing, Shanghai, Xi'an
2022-03-09
Recruiting
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
NCT05032053Ischemic Stroke
Xijing Hospital
Observational
3,000
Ankang, Hanzhong, Xi'an, Ya'an, Yunlin, Xianyang, Yan’an
2022-03-01
Recruiting
THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein
NCT05194423Tricuspid Valve Regurgitation
Changhai Hospital
Not applicable
150
Beijing, Guangzhou, Wuhan, Xi'an, Shanghai, Chengdu, Hangzhou
2022-03-01
Active, closed
Neoadjuvant Furmonertinib and Cisplatin/Pemetrexed as in EGFR Mutated Stage IIA-IIIB Resectable NSCLC (FORESEE)
NCT05430802Non-small Cell Lung Cancer
DrugFurmonertinib
Tang-Du Hospital
Phase 2
40
Xi'an
2022-02-24
Recruiting
Efficacy and Safety of SIRT-Y90 in Combination With Atezo + Bev for Unresectable Hepatocellular Carcinoma
NCT07610551HCC - Hepatocellular Carcinoma
Air Force Military Medical University, China
Observational
50
Xi’an
2022-02-09
Active, closed
China S3 PMS: SAPIEN 3 China Post Market Registry Study
NCT05168826Aortic Stenosis, Severe
Edwards Lifesciences
Observational
250
Beijing, Xiamen, Guangzhou, Zhengzhou, Wuhan, Changsha, Shanghai, Xi’an
2022-01-24
Active, closed
A Phase I Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors
NCT05114759Advanced Solid Tumors
DrugSHR-A2009
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
176
Chongqicun, Fuzhou, Guangzhou, Changsha, Nanchang, Changchun, Jinan, Xi’an
2022-01-04
Recruiting
Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding
NCT04662918GastroIntestinal Bleeding
Xingshun Qi
Observational
3,000
Beijing, Fuzhou, Wuhan, Nanchang, Dalian, Shenyang, Xi'an, Jinan
2022-01-01
Active, closed
A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)
NCT04819100Carcinoma, Non-Small-Cell Lung
DrugSelpercatinib
Eli Lilly and Company
Phase 3
152
Beijing, Fuzhou, Guangzhou, Harbin, Changsha, Changchun, Xi'an, Jinan
2021-12-20
Not yet open
Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH
NCT05043181Familial Hypercholesterolemia
Tang-Du Hospital
Phase 1
30
Xi'an
2021-12
Recruiting
A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging
NCT06834412Hematological Malignancies
Xijing Hospital
Not applicable
120
Xi'an
2021-11-03
Active, closed
1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated Balloon
NCT04971356Antiplatelet Drug, Acute Coronary Syndrome, Angioplasty, Balloon
Xijing Hospital
Not applicable
1,948
Xi'an
2021-11-01
Active, closed
Multi-centre Study to Evaluate ACAF Versus Laminoplasty in Treating Cervical Ossification of the Posterior Longitudinal Ligament
NCT04968028Ossification of Posterior Longitudinal Ligament, Cervical Spondylosis With Myelopathy
Shanghai Changzheng Hospital
Not applicable
167
Beijing, Shenzhen, Harbin, Jining, Qingdao, Shanghai, Taiyuan, Xi’an
2021-08-17
Active, closed
A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy
NCT04629248Primary Membranous Nephropathy
DrugsDiphenhydramine·Acetaminophen·Tacrolimus·Methylprednisolone
Hoffmann-La Roche
Phase 3
142
Hangzhou, Beijing, Chengdu, Fuzhou, Guangzhou, Shanghai, Wuhan, Xi'an
2021-06-25
Recruiting
68Ga-PSMA PET in the Renal Cell Carcinoma
NCT04987086Renal Cancer, Metastases, PSMA PET
Xijing Hospital
Not applicable
300
Lanzhou, Yinchuan, Xining, Xi'an, Weinan, Xianyang, Yan’an
2021-06-01
Recruiting
Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction
NCT04912518ST-segment Elevation Myocardial Infarction (STEMI), Percutaneous Coronary Intervention, Cardioprotection
DrugMidazolam
Harbin Medical University
Not applicable
250
Hefei, Lanzhou, Harbin, Mudanjiang, Zhengzhou, Wuhan, Xi'an, Taiyuan
2021-05-27
Active, closed
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
NCT04873362Breast Cancer
DrugsTrastuzumab emtansine·Atezolizumab·Trastuzumab
Hoffmann-La Roche
Phase 3
1,188
Chengdu, Chongqing, Guangzhou, Harbin, Shanghai, Tianjin, Wuhan, Xi'an
2021-05-04
Not yet open
Neoadjuvant PDT in the Treatment of Cholangiocarcinoma
NCT04824742Cholangiocarcinoma Resectable
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
50
Xi'an
2021-04-01
Recruiting
Mi-thos® Transcatheter Mitral Valve Replacement Study
NCT04195984Mitral Valve Regurgitation
Shanghai NewMed Medical Co., Ltd.
Not applicable
122
Beijing, Shanghai, Xi’an
2021-03-25
Recruiting
Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer
NCT07492927Clinically Significant Prostate Cancer
Xijing Hospital
Observational
1,700
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-12
By invitation
Plasma Exosome RNA to Diagnose Prostate Cancer
NCT06604130Prostate Cancer
Xijing Hospital
Not applicable
1,600
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-12
Recruiting
Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer
NCT07553780High-risk Prostate Cancer, PSMA PET, Treatment Response, Therapy Monitoring
Xijing Hospital
Observational
110
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-07
Recruiting
Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer
NCT07531329Treatment-naive Prostate Cancer, Suspected Prostate Cancer, Molecular Imaging
Xijing Hospital
Observational
1,000
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-05
Active, closed
Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC
NCT05400070Sintilimab, Lung Cancer, Anlotinib, Chemotherapy
Tang-Du Hospital
Phase 2
45
Xi'an
2021-03-01
Recruiting
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
NCT04634552Hematological Malignancies
DrugTalquetamab
Janssen Research & Development, LLC
Phase 2
510
Beijing, Guangzhou, Hangzhou, Suzhou, Tianjin, Xi'an
2021-02-01
Active, closed
Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions
NCT04561739De Novo Stenosis, Coronary Artery Disease
Xijing Hospital
Not applicable
2,272
Xi'an
2021-02-01
Active, closed
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
NCT04589845Solid Tumors
DrugsBelvarafenib·Ipatasertib·Pralsetinib·Divarasib
Hoffmann-La Roche
Phase 2
920
Beijing, Chengdu, Shanghai, Tianjin, Xi'an
2021-01-18
Active, closed
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
NCT04521231B Cell Precursor Acute Lymphoblastic Leukemia
DrugBlinatumomab
Amgen
Phase 1/2
181
Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Suzhou, Qingdao, Xi’an
2021-01-04
Active, closed
Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
NCT04562766Immune Thrombocytopenia
DrugRilzabrutinib
Principia Biopharma, a Sanofi Company
Phase 3
232
Wuhan, Shenyang, Xi'an, Jinan, Tianjin, Kunming, Hangzhou, Hefei
2020-12-14
Active, closed
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
NCT04576455Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
DrugsGiredestrant·Fulvestrant
Hoffmann-La Roche
Phase 2
303
Changchun, Guangzhou, Linyi, Nanchang, Shanghai, Tianjin, Wuhan, Xi'an
2020-11-27
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT04606446Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
DrugsPF-07248144·PF-07220060·Palbociclib·Letrozole
Pfizer
Phase 2
320
Beijing, Guangzhou, Changchun, Xi'an
2020-11-16
Recruiting
Nutritional Status and Clinical Outcomes in Patients With Common Malignancies(NCOM)
NCT06219083Cancer, Chemoradiotherapy, Nutrition, Healthy, Oncology
Xiaoqin Luo
Observational
1,538
Xi'an
2020-11-12
Recruiting
Abbott Vascular Medical Device Registry
NCT04573660Acute Myocardial Infarction, Restenoses, Coronary, Coronary Artery Lesions, Venous Embolism
Abbott Medical Devices
Observational
3,784
Xi'an, Jinhua, Ningbo
2020-10-25
Active, closed
Myasthenia Gravis Inebilizumab Trial
NCT04524273Myasthenia Gravis
DrugInebilizumab
Amgen
Phase 3
238
Beijing, Guiyang, Hunan, Jinan, Shanghai, Suzhou, Tianjin, Xi'an
2020-10-15
Recruiting
Assess the Risk of Cerebrovascular Disease
NCT04443439Cerebrovascular Disease
Tang-Du Hospital
Observational
100
Xi'an
2020-10-09
Recruiting
Screening for Early Gastric Cancer in Shaanxi Province
NCT05291728Early Gastric Cancer
Second Affiliated Hospital of Xi'an Jiaotong University
Observational
12,500,000
Xi'an
2020-10-01
Active, closed
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
NCT04557449Liposarcoma, Prostate Cancer, Breast Neoplasms, Adenocarcinoma of Lung
DrugsPF-07220060·Midazolam
Pfizer
Phase 2
362
Beijing, Zhengzhou, Wuhan, Xi’an, Hangzhou
2020-09-23
Active, closed
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
NCT04557098Hematological Malignancies
DrugTeclistamab
Janssen Research & Development, LLC
Phase 2
194
Beijing, Chengdu, Guangzhou, Hangzhou, Shanghai, Shenyang, Tianjin, Xi'an
2020-09-17
Active, closed
Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance
NCT04285086Essential Thrombocythemia
DrugsAnagrelide·Ropeginterferon alfa-2b
PharmaEssentia
Phase 3
174
Beijing, Chongqing, Guangzhou, Wuhan, Suzhou, Shenyang, Xi'an, Jinan
2020-08-25
Recruiting
Myocardialbridge Bypass Graft Surgery Efficacy Verification
NCT06857838Myocardial Bridge of Coronary Artery, Myocardial Bridge, Myocardial Bridging, Myocardial Infarction
Xi'an International Medical Center Hospital
Not applicable
500
Xi'an
2020-01-01
Recruiting
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
NCT04078230Intrahepatic Cholangiocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
168
Beijing, Guangzhou, Changsha, Hohhot, Shanghai, Xi’an, Chengdu, Hanzhou
2020-01-01
Active, closed
Exploratory Study of 3D Printed Biodegradable Cervical Interbody Fusion Cage
NCT04167878Symptomatic Cervical Disc Disease
Xijing Hospital
Not applicable
10
Xi'an
2019-12-01
Recruiting
TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study
NCT04182984Ocular Myasthenia Gravis
Tang-Du Hospital
Observational
200
Xi'an
2019-11-04
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Tianjin, Xi'an, Hangzhou
2019-10-03
Recruiting
Pan Tumor Rollover Study
NCT03899155Cancer
DrugsRucaparib·Relatlimab·Sunitinib·Cabozantinib
Bristol-Myers Squibb
Phase 2
1,500
Hefei, Beijing, Guangzhou, Harbin, Changsha, Nanjing, Changchun, Xi'an
2019-08-09
Recruiting
Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients
NCT03987308Type 2 Diabetic Patients, T2DM (Type 2 Diabetes Mellitus), T2DM
DrugInsulin aspart
Beijing Hospital
Not applicable
115
Beijing, Guangzhou, Harbin, Nanjing, Xuzhou, Changchun, Xi'an, Luzhou
2019-07-02
Active, closed
Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study
NCT03886246Generalized Pustular Psoriasis
DrugSpesolimab
LEO Pharma
Phase 2
131
Guangzhou, Hangzhou, Shanghai, Xi'an
2019-05-29
Active, closed
Acute Normovolemic Hemodilution in High Risk Cardiac Surgery Patients.
NCT03913481C.Surgical Procedure; Cardiac
Università Vita-Salute San Raffaele
Not applicable
2,000
Xi'an
2019-04-15
Recruiting
Comparative Effectiveness Between Indomethacin and Pancreatic Stenting in the Prevention of Post ERCP Pancreatitis
NCT03713879Post ERCP Pancreatitis
Chinese University of Hong Kong
Phase 3
1,734
Xi'an, Shanghai, Tianjin, Hangzhou
2019-03-21
Recruiting
A Single-Center, Retrospective, Propensity-Score-Matched Cohort Study Comparing Drug-Coated Balloon Versus Drug-Eluting Stent for Reducing Immediate Post-Procedural Slow-Flow/No-Reflow in Acute ST-Elevation Myocardial Infarction Patients With High Thrombus Burden
NCT07806370ST Elevation Myocardial Infarction (STEMI), Acute Coronary Syndromes (ACS)
Xijing Hospital
Observational
668
Xi'an
2019-01-01
Recruiting
Transcatheter Aortic Valve Replacement for Pure Severe Aortic Valve Regurgitation
NCT06381271Aortic Valve Regurgitation
Xijing Hospital
Observational
500
Xi'an
2018-10-30
Active, closed
Effects of Closed-loop Automatic Control of FiO2 in Extremely Preterm Infants
NCT03168516Infant,Premature
University Hospital Tuebingen
Phase 3
1,065
Xi'an
2018-07-27
Recruiting
A New Parameter Derived From DSA to Evaluate Cerebral Perfusion
NCT03607565Cerebral Ischemia
Xi'an No.3 Hospital
Observational
30,000
Xi'an
2018-07-15
Recruiting
Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome
NCT05965453Acute Aortic Syndrome
First Affiliated Hospital Xi'an Jiaotong University
Observational
205
Xi'an
2018-06-01
Active, closed
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
NCT03425643Non-small Cell Lung Cancer
DrugsGemcitabine·Pemetrexed·Cisplatin·Pembrolizumab
Merck Sharp & Dohme LLC
Phase 3
797
Tianjin, Beijing, Guangzhou, Changsha, Shanghai, Xi’an, Hangzhou, Ningbo
2018-04-24
Recruiting
Peripheral Blood Lipidomic and Ceramide Profiles in Atrial Fibrillation
NCT07757282Atrial Fibrillation (AF)
First Affiliated Hospital Xi'an Jiaotong University
Observational
200
Xi'an
2017-06-15
Recruiting
Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)
NCT06365424Primary Biliary Cholangitis
Xijing Hospital of Digestive Diseases
Phase 2/3
117
Xi'an
2017-04-08
Active, closed
Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery
NCT03012971Elderly, Surgery, Analgesia, Dexmedetomidine
Peking University First Hospital
Not applicable
1,500
Beijing, Chongqing, Guiyang, Baoding, Changsha, Xi'an, Qingdao, Taiyuan
2017-01-06
Active, closed
Long-term Outcomes of Patients Undergoing ECMO-assisted PCI
NCT06713876Complex High-risk and Indicated Patients
Ling Tao, MD, PhD
Observational
220
Xi'an
2016-08-01
Active, closed
Establishment of a Model for Predicting the Prognosis of HBV-related Decompensated Liver Cirrhosis Based on RFH-NPT
NCT05513651Liver Cirrhosis, Malnutrition
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2016-07-01
Recruiting
Long-term Prognosis and Valve Durability of TAVR
NCT06379386Aortic Valve Stenosis and Insufficiency
Xijing Hospital
Observational
1,000
Xi'an
2016-01
Active, closed
Drug-coated Balloons and Drug-eluting Stents in Diabetic Patients
NCT05937230Coronary Heart Disease, Angioplasty, Balloon
Xijing Hospital
Observational
1,500
Xi'an
2015-06-01
Rows per page Showing 401–500 of 504
Previous 3 4 5 6 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/xi-an?page=5

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 504 of those studies with a site in Xi’an.

How many clinical trials are recruiting in Xi’an?

314 of the 504 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 94 have not yet opened recruitment, 77 are active but closed to new participants, and 19 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.